Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes on metformin
2013-005500-33Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Insulin detemir arm with Insulin human NPH arm (2 arms). Primary endpoint: Change in HbA1c. Started Jun 2014; status: terminated.
02
Drugs
insulin detemirinsulin isophane
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-005500-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005500-33.